Authors: Koukourakis, MI Corti, L Skarlatos, J Giatromanolaki, A Krammer, B Blandamura, S Piazza, M Verwanger, T Schnitzhofer, G Kostandelos, J Beroukas, K

Citation: Mi. Koukourakis et al., Clinical and experimental evidence of bcl-2 involvement in the response tophotodynamic therapy, ANTICANC R, 21(1B), 2001, pp. 663-668

Authors: Lagerberg, JWM Uberriegler, KP Krammer, B VanSteveninck, J Dubbelman, TMAR

Citation: Jwm. Lagerberg et al., Plasma membrane properties involved in the photodynamic efficacy of merocyanine 540 and tetrasulfonated aluminum phthalocyanine, PHOTOCHEM P, 71(3), 2000, pp. 341-346

Authors: Reiter, I Schwamberger, G Krammer, B

Citation: I. Reiter et al., Activation of macrophage tumoricidal activity by photodynamic treatment invitro - indirect activation of macrophages by photodynamically killed tumor cells, J PHOTOCH B, 50(2-3), 1999, pp. 99-107

Authors: Koukourakis, MI Giatromanolaki, A O'Byrne, KJ Cox, J Krammer, B Gatter, KC Harris, AL

Citation: Mi. Koukourakis et al., bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer, CLIN EXP M, 17(7), 1999, pp. 545-554

Authors: Reiter, I Krammer, B Schwamberger, G

Citation: I. Reiter et al., Cutting edge: Differential effect of apoptotic versus necrotic tumor cellson macrophage antitumor activities, J IMMUNOL, 163(4), 1999, pp. 1730-1732

Authors: Verwanger, T Schnitzhofer, G Krammer, B

Citation: T. Verwanger et al., Expression kinetics of the (proto)oncogenes c-myc and bcl-2 following photodynamic treatment of normal and transformed human fibroblasts with 5-aminolaevulinic acid-stimulated endogenous protoporphyrin IX, J PHOTOCH B, 45(2-3), 1998, pp. 131-135